Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.
about
Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia.Setting the stage for universal financial distress screening in routine cancer care.Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.
P2860
Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Oral Chemotherapy in Patients ...... nomic and Policy Implications.
@en
type
label
Oral Chemotherapy in Patients ...... nomic and Policy Implications.
@en
prefLabel
Oral Chemotherapy in Patients ...... nomic and Policy Implications.
@en
P2093
P2860
P1476
Oral Chemotherapy in Patients ...... nomic and Policy Implications.
@en
P2093
Elizabeth Dow
Jeffrey Betcher
Nandita Khera
P2860
P2888
P304
P356
10.1007/S11899-016-0325-2
P577
2016-04-16T00:00:00Z
P6179
1020621403